Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia-The PROGRESS Pilot Study
Phase of Trial: Phase III
Latest Information Update: 09 May 2018
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Preeclampsia
- Focus Therapeutic Use
- Acronyms PROGRESS
- 01 May 2018 Planned End Date changed from 31 Jan 2018 to 31 Jan 2020.
- 01 May 2018 Planned primary completion date changed from 31 Jan 2018 to 31 Jan 2020.
- 16 Aug 2017 Status changed from not yet recruiting to recruiting.